TipRanks
55% OFF
PC:LPOXY

LPOXY Therapeutics Inc

LPOXY Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing SIDIPREV™, a novel non-antibiotic therapy aimed at preventing Clostridioides difficile infections. This innovative therapy, delivered as an orally administered, enteric-coated capsule, releases oxygen into the lower gastrointestinal tract to create an environment hostile to anaerobic pathogens, addressing a critical unmet need in infection prevention for high-risk hospitalized patients.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$28M
Total Funding Rounds
1
Latest Funding Amount
$28M
Latest Funding Round
Series A
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 03, 2025Series A$28.00M―

Investors

Investor NameFunding Round
5 Horizons Ventures, LLCSeries A

Similar Companies

A snapshot of private companies similar to LPOXY Therapeutics Inc, helping you discover and navigate related company profiles.

Related News and Analysis